Vivos (RDGL) Shares Outstanding (2010 - 2026)
Vivos' (RDGL) quarterly Shares Outstanding (Entity) came in at $494.2 million in Q2 2026, up 8.9% year-over-year from $453.8 million in Q2 2025, and up 8.5% quarter-over-quarter from $455.5 million in Q4 2025.
Analysis
Vivos (RDGL) Shares Outstanding (2010 - 2026) Analysis & Trends
Vivos has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $494.2 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 8.9% year-over-year to $494.2 million; the TTM figure through Jun 2026 stood at $494.2 million (up 8.9% YoY), while the FY2025 annual figure was $455.5 million, up 3.32% from the prior year.
- Shares Outstanding (Entity) came in at $494.2 million for Q2 2026 at Vivos, up from $455.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $494.2 million in Q2 2026 to a low of $343.9 million in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $404.7 million, with a median of $390.0 million recorded in 2024.
- Year-over-year, Shares Outstanding (Entity) gained 2.68% in 2022 and advanced 16.25% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $362.5 million in 2022, then climbed by 6.99% to $387.9 million in 2023, then advanced by 13.66% to $440.9 million in 2024, then grew by 3.32% to $455.5 million in 2025, then increased by 8.5% to $494.2 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $494.2 million in Q2 2026, $455.5 million in Q4 2025, and $454.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | 490.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 490.70 Mn |
| Dec 31, 2025 | 452.72 Mn |
| Sep 30, 2025 | 454.30 Mn |
| Jun 30, 2025 | 453.51 Mn |
| Mar 31, 2025 | 448.23 Mn |
| Dec 31, 2024 | 409.67 Mn |
| Sep 30, 2024 | 418.63 Mn |
| Jun 30, 2024 | 403.38 Mn |
| Mar 31, 2024 | 389.41 Mn |
| Dec 31, 2023 | 368.81 Mn |
| Sep 30, 2023 | 370.54 Mn |
| Jun 30, 2023 | 368.17 Mn |
| Mar 31, 2023 | 362.54 Mn |
| Dec 31, 2022 | 351.43 Mn |
| Sep 30, 2022 | 358.75 Mn |
| Jun 30, 2022 | 343.91 Mn |
| Mar 31, 2022 | 343.61 Mn |
| Dec 31, 2021 | 325.85 Mn |
| Sep 30, 2021 | 335.51 Mn |
| Jun 30, 2021 | 328.22 Mn |